Cargando…
Exploring the misalignment on the value of further research between payers and manufacturers. A case study on a novel total artificial heart
Payers and manufacturers can disagree on the appropriate level of evidence that is required for new medical devices, resulting in high societal costs due to decisions taken with sub‐optimal information. A cost‐effectiveness model of a hypothetical total artificial heart was built using data from the...
Autores principales: | Federici, Carlo, Pecchia, Leandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546170/ https://www.ncbi.nlm.nih.gov/pubmed/35460307 http://dx.doi.org/10.1002/hec.4520 |
Ejemplares similares
-
Examining Misaligned Incentives for Payers and Manufacturers in Value-Based Pharmaceutical Contracts
por: Kannarkat, Joseph T., et al.
Publicado: (2020) -
Biosimilars: Opportunities to Promote Optimization Through Payer and Provider Collaboration
por: Manolis, Chronis H., et al.
Publicado: (2016) -
Abstract 101: Impact Of Insurance Payer On Type Of Breast Reconstruction Performed
por: Gabrick, Kyle, et al.
Publicado: (2019) -
Abstract 184: The Effect Of Insurance Payer Type On Outcomes And Readmission Rates In Patients Undergoing Breast Reconstruction
por: Marquez, Jocellie, et al.
Publicado: (2020) -
The NICE Medical Technologies Evaluation Programme (MTEP): manufacturer submission challenges
por: Sprange, Kirsty, et al.
Publicado: (2012)